Press release
Global Peptide Therapeutics Market will multiply at an impressive USD 26.2 Billion by 2023 & Top Key Players Bachem Holding AG, CordenPharma International GmbH, Eli Lilly and Company, Ipsen S.A., Merck & Co., Novo Nordisk A/S and PolyPeptide Group.
The peptide therapeutics market has been segmented by application into cancer, cardiovascular, central nervous system, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, respiratory disorders, acromegaly and other applications. Among these segments, the cancer segment is estimated to observe high growth in upcoming years. This can be attributed to rising number of cancer patients across the globe. Further, technical innovations and rise in research and development activities for new treatment and drugs are some of the factors that are anticipated to drive the growth of cancer segment in overall peptide therapeutics market with noteworthy revenue by the end of 2023.
The Global Peptide Therapeutics Market is anticipated to reach market valuation of USD 26.2 Billion by 2023 as compared to USD 15.6 Billion in 2015 by expanding at a significant compound annual growth rate of 8.2% over the period 2016-2023. Factors such as rising clinical drug researches in order to treat cancers and other disorders and introduction of advanced cost effective therapeutic peptides combined with their safety and effectiveness is anticipated to propel the growth of peptide therapeutics market in upcoming years.
Request Report Sample @https://www.researchnester.com/sample-request/2/rep-id-180
In the regional segment, North America accounted for USD 7.42 Billion in 2015 and is expected to continue its dominance in overall peptide therapeutics market across the globe by expanding at a compound annual growth rate of 6.9% over the period 2016-2023. This can be attributed to escalation of pharmaceutical and biotech companies across the region. Further, the presence of large number of biotech companies in Europe is estimated to make Europe as the second largest share contributor in peptide therapeutics market across the globe. Moreover, rising prevalence of cancer and nervous system disorders combined with increasing healthcare spending by the government establishments is anticipated to drive the demand for peptide therapeutics in Asia Pacific region.
Research Laboratories & Preference towards Peptide Therapeutics by Doctors to Boom the Market
Growing geriatric population is predicted to expand the demand for peptide therapeutics owing to prevalence of rising health diseases such as cardiac, cardiovascular and osteoporosis among others. Further, the rise is biotech companies and preference by physicians towards peptide therapeutics combined with cumulative demand in research laboratories to produce more effective drugs for the treatment of cancer is believed to supplement the growth of peptide therapeutics market across the globe. However, increasing cost and presence of stringent regulatory controls for peptide therapeutics is likely to inhibit the growth of the peptide therapeutics market in the near future.
Request for TOC Here @https://www.researchnester.com/toc-request/1/rep-id-180
The report titled “Peptide Therapeutics Market: Global Market Size, Demand Analysis & Opportunity Outlook 2023” delivers detailed overview of the peptide therapeutics market in terms of market segmentation by application, by drugs type, by end-user and by region.Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
This report also provides the existing competitive scenario of some of the key players of the peptide therapeutics market which includes company profiling of Bachem Holding AG, CordenPharma International GmbH, Eli Lilly and Company, Ipsen S.A., Merck & Co., Novo Nordisk A/S and PolyPeptide Group. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the peptide therapeutics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Buy This Premium Reports Now @https://www.researchnester.com/payment/rep-id-180
For more details visit @https://www.researchnester.com/reports/peptide-therapeutics-market-global-market-size-demand-analysis-opportunity-outlook-2023/180
Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision so as to avoid future uncertainties.
Ajay Daniel
Email: ajay.daniel@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Peptide Therapeutics Market will multiply at an impressive USD 26.2 Billion by 2023 & Top Key Players Bachem Holding AG, CordenPharma International GmbH, Eli Lilly and Company, Ipsen S.A., Merck & Co., Novo Nordisk A/S and PolyPeptide Group. here
News-ID: 1222671 • Views: …
More Releases from Research Nester Pvt Ltd
Vegan Food Market: Size is Expected to Surpass USD 91.83 billion by 2035
Research Nester, the global vegan food market size is predicted to expand at a CAGR of 11.8% between 2026 and 2035, on account of the rising awareness of people about fitness globally.
Request Free Sample Report @ https://www.researchnester.com/sample-request-6172
The Increasing Demand for Vegan Food Globally Will Increase the Global Market Share of Vegan Food Market
By the end of 2035, the vegan food sector will have grown significantly and appear extremely promising. Several…
U.S. Cogeneration Equipment Market Forecast to Exhibit Robust Growth During 2026 …
The U.S. cogeneration equipment market is poised for robust advancement throughout the forecast period from 2026 to 2035, driven primarily by the nation's growing focus on energy efficiency and decarbonization. Increasing regulatory emphasis on sustainable energy use, coupled with corporate commitments to reduce carbon footprints, is stimulating widespread adoption of combined heat and power (CHP) systems across industrial, commercial, and institutional sectors. The integration of cogeneration technologies aligns with the…
U.S. Coal Gasification Market Size is Expected to Witness Accelerated Expansion …
The U.S. coal gasification market is expected to witness robust expansion during the forecast period from 2026 to 2035, driven primarily by the nation's push toward cleaner energy conversion technologies and carbon utilization strategies. The growing emphasis on decarbonizing heavy industries and enhancing domestic energy security has positioned coal gasification as a pivotal pathway for transforming coal into cleaner synthesis gas, hydrogen, and chemical feedstocks. Advancements in carbon capture and…
U.S. Nuclear Fusion Market Size is Projected to Record Sustained Growth Through …
The U.S. nuclear fusion market is expected to experience strong growth throughout the forecast period from 2026 to 2035, driven primarily by technological breakthroughs in plasma confinement and increasing public-private investment in next-generation energy systems. As the country accelerates its transition toward low-carbon and sustainable power solutions, fusion energy has emerged as a promising alternative to traditional nuclear fission. Innovations in superconducting magnets, laser systems, and artificial intelligence-driven plasma control…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
